Cubist Systematic Strategies’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Cubist Systematic Strategies’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-35,717	Closed	-$124K	–	3888
2023 Q1	$124K	Buy	35,717 +6,609	+23%	+$32K	﹤0.01%	3395
2022 Q4	$122K	Buy	29,108 +12,243	+73%	+$46.4K	﹤0.01%	3751
2022 Q3	$68K	Sell	16,865 -84,578	-83%	-$642K	﹤0.01%	4083
2022 Q2	$1.15M	Sell	101,443 -4,700	-4%	-$56.3K	0.01%	2372
2022 Q1	$1.72M	Buy	106,143 +105,599	+19,412%	+$2.71M	0.01%	1605
2021 Q4	$26K	Sell	544 -6,156	-92%	-$369K	﹤0.01%	3364
2021 Q3	$486K	Sell	6,700 -41,326	-86%	-$2.99M	0.01%	2055
2021 Q2	$4.03M	Buy	48,026 +36,084	+302%	+$2.38M	0.05%	661
2021 Q1	$579K	Buy	+11,942	New	+$648K	0.01%	1880

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cubist Systematic Strategies's NBP Position: Q2 2023 in Review

Cubist Systematic Strategies sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2023, closing a stake of 35,717 shares — an estimated $124K sold.

Cubist Systematic Strategies first reported a position in NBP in Q1 2021 and held it in 9 quarters. The position peaked at $4.03M in Q2 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q2 2023.

Cubist Systematic Strategies reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 35,717 NovaBridge Biosciences American Depositary Shares shares in Q2 2023, an estimated $124K.
Cubist Systematic Strategies first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2021 and held it in 9 quarters.
Cubist Systematic Strategies's NovaBridge Biosciences American Depositary Shares position peaked at $4.03M in Q2 2021.
48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2023.

Based on Cubist Systematic Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.